January 2, 2024 · Form 4 insider transaction
Martin Samuel Bates bought 10,750 shares of Celldex Therapeutics, Inc. at $2.78 per share, a transaction worth $29.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.